The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Aleta Biotherapeutics
Stock and Other Ownership Interests - Aleta Biotherapeutics
Patents, Royalties, Other Intellectual Property - Aleta Biotherapeutics
Activity of CAR19 T cells secreting ​impact fusion proteins against hematopoietic and solid tumors.
 
Fay Dufort
Employment - Aleta Biotherapeutics
Stock and Other Ownership Interests - Aleta Biotherapeutics; Bristol-Myers Squibb
Research Funding - Aleta Biotherapeutics (Inst)
 
Lihe Su
Employment - Aleta Biotherapeutics
Stock and Other Ownership Interests - Biogen
Research Funding - Aleta Biotherapeutics (Inst)
 
Lan Wu
Employment - Aleta Biotherapeutics
Stock and Other Ownership Interests - Biogen; Dow Chemical Company (I)
Research Funding - Aleta Biotherapeutics (Inst)
 
Alyssa Birt
Employment - Aleta Biotherapeutics
Stock and Other Ownership Interests - Bluebird Bio
Research Funding - Aleta Biotherapeutics
 
Roy Lobb
Leadership - Aleta Biotherapeutics
Stock and Other Ownership Interests - Aleta Biotherapeutics
Consulting or Advisory Role - Aleta Biotherapeutics
Patents, Royalties, Other Intellectual Property - Aleta Biotherapeutics
Travel, Accommodations, Expenses - Aleta Biotherapeutics
 
Christine Ambrose
Employment - Aleta Biotherapeutics; Pfizer (I)
Stock and Other Ownership Interests - Biogen; Pfizer (I)
Research Funding - Aleta Biotherapeutics (Inst)
 
Paul Rennert
No Relationships to Disclose